Somé, Nibene H.
Shokoohi, Mostafa
Shield, Kevin D.
Wells, Samantha
Hamilton, Hayley A.
Elton-Marshall, Tara
Abramovich, Alex
Article History
Received: 10 August 2021
Accepted: 15 February 2022
First Online: 7 March 2022
Declarations
:
: The study has been granted ethics committee approval from the Research Ethics Board at the Centre for Addiction and Mental Health, Toronto, ON, Canada. The Centre For Addiction and Mental Health Research Ethics Board (CAMH REB) operates in compliance with, and is constituted in accordance with, the requirements of the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2), the International Conference on Harmonisation Good Clinical Practice Consolidated Guideline (ICH GCP), Part C, Division 5 of the Food and Drug Regulations, Part 4 of the Natural Health Products Regulations, Part 3 of the Medical Devices Regulations, and the provisions of the Ontario Personal Health Information Protection Act (PHIPA 2004) and its applicable regulations. The CAMH REB is qualified through the CTO REB Qualification Program and is registered with the US Department of Health and Human Services (DHHS) Office for Human Research Protection (OHRP). All participants provided written consent to participate.
: N.A.
: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.